← All trials
NCT06157541
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2024
- Primary completion
- Aug 31, 2026
- Completion date
- Jan 31, 2028
- First posted
- Dec 6, 2023
- Last posted
- Dec 12, 2023
- Enrollment
- 58
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of QueenslandLead sponsor
- University of MelbourneCollaborator
- MerckCollaborator
- University of SydneyCollaborator
- University of QueenslandOverall official - principal investigator
- University of QueenslandCollaborator
- University of QueenslandOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.